Shifts in insulin use

Changes in technology and drug prices have affected how physicians manage patients with insulin-treated diabetes.

An article in the January I.M. Matters from ACP describes how physicians' management of insulin treatment is changing.

Recent federal legislative changes, as well as caps set by insulin manufacturers and some state laws, have provided price relief for patients, depending upon their insurance coverage. Meanwhile, continuous glucose monitoring systems have become easier for patients to use, and both price and insurance coverage of these devices have improved, making them more accessible to patients with type 2 diabetes.